Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice (Q43124445)

14 November 2017

title

Pitavastatin reduces oxidative stress and attenuates intermittent hypoxia-induced left ventricular remodeling in lean mice (English)

1 reference

14 November 2017

main subject

ventricular remodeling

1 reference

Sakiko Inamoto

1

1 reference

14 November 2017

Toshitaka Yoshioka

2

1 reference

14 November 2017

Chika Yamashita

3

1 reference

14 November 2017

Masatoshi Miyamura

4

1 reference

14 November 2017

Tatsuhiko Mori

5

1 reference

14 November 2017

Akira Ukimura

6

1 reference

14 November 2017

Chika Matsumoto

7

1 reference

14 November 2017

Yasuo Matsumura

8

1 reference

14 November 2017

Yasushi Kitaura

9

1 reference

14 November 2017

Tetsuya Hayashi

10

1 reference

14 November 2017

publication date

19 March 2010

1 reference

14 November 2017

published in

Hypertension Research

1 reference

14 November 2017

volume

33

1 reference

14 November 2017

issue

6

1 reference

14 November 2017

page(s)

579-586

1 reference

Obstructive sleep apnea and cardiovascular disease

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Obstructive sleep apnea: implications for cardiac and vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Rosuvastatin reduces atherosclerosis development beyond and independent of its plasma cholesterol-lowering effect in APOE*3-Leiden transgenic mice: evidence for antiinflammatory effects of rosuvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

C-reactive protein levels and outcomes after statin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Attenuation of chronic hypoxic pulmonary hypertension by simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Statins augment collateral growth in response to ischemia but they do not promote cancer and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Pitavastatin, an HMG-CoA reductase inhibitor, exerts eNOS-independent protective actions against angiotensin II induced cardiovascular remodeling and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Volume overload results in exaggerated cardiac hypertrophy in the atrial natriuretic peptide knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Angiotensin II receptor blocker reduces oxidative stress and attenuates hypoxia-induced left ventricular remodeling in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Nifedipine enhances the cardioprotective effect of an angiotensin-II receptor blocker in an experimental animal model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Chronic hypoxia accelerates the progression of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Intermittent hypoxia induces early functional cardiovascular remodeling in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Reactive oxygen metabolites (ROMs) as an index of oxidative stress in obstructive sleep apnea patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Obstructive sleep apnoea syndrome--an oxidative stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

NADPH oxidase: a universal oxygen sensor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Activation of NADPH oxidase during progression of cardiac hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Chymase plays an important role in left ventricular remodeling induced by intermittent hypoxia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-kappaB (NF-kappaB) transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Angiotensin II induces tumor necrosis factor biosynthesis in the adult mammalian heart through a protein kinase C-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Dog mastocytoma cells produce transforming growth factor beta 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Chymase induces profibrotic response via transforming growth factor-beta 1/Smad activation in rat cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Role of mast cells in hepatic remodeling during cholestasis and its resolution: relevance to regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Effects of long-term intermittent hypoxia on mitochondrial and Fas death receptor dependent apoptotic pathways in rat hearts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Overexpression of transforming growth factor-beta1 and insulin-like growth factor-I in patients with idiopathic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2010.36

7 January 2021

Identifiers

DOI

10.1038/HR.2010.36

1 reference

14 November 2017

1 reference